vertex pharmaceuticals - Search News

The Motley Fool · 1d

Should You Buy Vertex Pharmaceuticals Stock Hand Over Fist Before Jan. 30?

Vertex Pharmaceuticals ( VRTX 3.06%) might be one of those special cases. Should you buy Vertex stock hand over fist before Jan. 30? What's so special about Jan. 30 for Vertex? It's the PDUFA action date set by the U.S. Food and Drug Administration (FDA) for making an approval decision on suzetrigine in treating acute pain.

MarketWatch · 1d

Vertex Pharmaceuticals Inc. stock underperforms Thursday when compared to competitors

Vertex Pharmaceuticals Inc. closed 19.80% below its 52-week high of $519.88, which the company reached on November 8th.

Zacks.com on MSN · 2d

Here is What to Know Beyond Why Vertex Pharmaceuticals Incorporated (VRTX) is a Trending Stock

Vertex Pharmaceuticals (VRTX) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to consider some of the key factors that could influence the stock's performance in the near future.

MarketBeat on MSN1d

Vertex's Pain Drug: Big Pharma's Next Major Success?

Vertex Pharmaceuticals (NASDAQ: VRTX) is a biotechnology company with a strong track record of success in developing ...

1d

HHS Challenges Vertex Over Fertility Services Program Tied To Casgevy Gene Therapy, Says Company Is 'Grasping at Straws'

HHS challenges Vertex Pharmaceuticals' fertility services program, alleging violations of anti-kickback laws linked to its ...

2d

Vertex Pharmaceuticals Inc. stock outperforms competitors on strong trading day

Vertex Pharmaceuticals Inc. closed 18.39% short of its 52-week high of $519.88, which the company reached on November 8th.

HHS Says Vertex is ‘Grasping at Straws’ With Casgevy Fertility Suit

Along with its gene editing therapy Casgevy, Vertex is offering fertility preservation support for its patients—a program ...

2don MSN

McKesson, Vertex Pharmaceuticals among top healthcare Quant picks before Q4 earnings

The S&P 500’s health care sector (NYSEARCA:XLV), holding a weightage of 12.12% in the S&P 500 index, saw a fall of 10.2% in ...

precisionmedicineonline15h

HHS Calls Vertex's Case for Fertility Program a 'Distraction,' Urges Court to Rule in Its Favor

HHS is asking the court to affirm its Office of Inspector General's finding that paying for fertility services would run ...

3d

Vertex Pharmaceuticals: Strategic Advancements and Promising Pipeline Drive Buy Rating

Analyst Evan Seigerman of BMO Capital maintained a Buy rating on Vertex Pharmaceuticals (VRTX – Research Report), retaining the price target of ...

3d

Vertex Pharmaceuticals’ (VRTX) “Outperform” Rating Reaffirmed at William Blair

Vertex Pharmaceuticals (NASDAQ:VRTX – Get Free Report)‘s stock had its “outperform” rating reaffirmed by stock analysts at ...

3d

Vertex Pharmaceuticals Sets Sight on Expanding Portfolio with Alyftrek Approval, Pain Treatment Progress, and Diabetes Trials

It can generate billions in revenue from both acute and possibly chronic pain. If approved, it would give Vertex ...

3d

Vertex Pharmaceuticals: Balancing Growth Prospects and Uncertainties with a Hold Rating

Morgan Stanley analyst Terence Flynn maintained a Hold rating on Vertex Pharmaceuticals (VRTX – Research Report) today and set a price target ...

3d

Here's How Much $100 Invested In Vertex Pharmaceuticals 10 Years Ago Would Be Worth Today

Vertex Pharmaceuticals VRTX has outperformed the market over the past 10 years by 1.52% on an annualized basis producing an ...

Results that may be inaccessible to you are currently showing.

Hide inaccessible results